J Luis Espinoza Selected Research

Toll-Like Receptor 1

7/2017	Toll-like receptor genetic variations in bone marrow transplantation.
1/2016	Toll-like receptor 1 variation increases the risk of transplant-related mortality in hematologic malignancies.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

J Luis Espinoza Research Topics

Disease

15	Neoplasms (Cancer) 03/2022 - 01/2013
10	Hematologic Neoplasms (Hematological Malignancy) 02/2020 - 10/2009
7	Graft vs Host Disease (Graft-Versus-Host Disease) 10/2021 - 01/2011
6	Infections 01/2022 - 07/2017
5	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2021 - 01/2015
5	Aplastic Anemia (Anemia, Hypoplastic) 01/2020 - 01/2009
4	Leukemia 01/2017 - 08/2009
3	Myeloid Leukemia (Leukemia, Myelocytic) 01/2020 - 03/2010
2	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 02/2022 - 08/2021
2	Chromosome Aberrations (Chromosome Abnormalities) 01/2018 - 01/2017
1	Persistent Infection 10/2021
1	Papillomavirus Infections 10/2021
1	Intracranial Hypertension 01/2020
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 01/2020
1	Sarcoidosis (Schaumann Disease) 06/2019
1	Inborn Genetic Diseases (Disease, Hereditary) 01/2019
1	Iron Overload 01/2019
1	Heart Diseases (Heart Disease) 01/2019
1	Fibrosis (Cirrhosis) 01/2019
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2019
1	Liver Diseases (Liver Disease) 01/2019
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 09/2018
1	Eosinophilia 01/2018
1	Carcinogenesis 01/2018
1	Dysbiosis 01/2018
1	Inflammation (Inflammations) 01/2017
1	Lymphoma (Lymphomas) 01/2016
1	Communicable Diseases (Infectious Diseases) 01/2016
1	Polycythemia Vera 11/2015
1	Renal Insufficiency (Renal Failure) 01/2015
1	Necrosis 01/2015
1	Diabetic Neuropathies (Diabetic Neuropathy) 01/2015
1	Dementia (Dementias) 01/2015
1	Ulcerative Colitis 01/2011
1	Autoimmune Diseases (Autoimmune Disease) 01/2011

Drug/Important Bio-Agent (IBA)

5	ResveratrolIBA 01/2019 - 01/2013
4	Rituximab (Mabthera)FDA Link 02/2022 - 01/2016
4	Biological ProductsIBA 10/2021 - 08/2016
4	Proteins (Proteins, Gene)FDA Link 03/2021 - 12/2010
3	Bendamustine Hydrochloride FDA Link 02/2022 - 09/2018
3	LigandsIBA 03/2021 - 03/2010
3	PolyphenolsIBA 01/2019 - 01/2013
3	moesinIBA 12/2010 - 01/2009
3	AntibodiesIBA 12/2010 - 01/2009
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 01/2020
2	Carbapenems (Carbapenem Antibiotics)IBA 01/2022 - 01/2020
2	micaIBA 03/2021 - 03/2010
2	Chlorpromazine (Thorazine)FDA Link 01/2021 - 01/2020
2	HLA Antigens (Human Leukocyte Antigens)IBA 02/2020 - 01/2019
2	NK Cell Lectin-Like Receptor Subfamily KIBA 06/2019 - 12/2016
2	CytokinesIBA 01/2019 - 01/2011
2	Toll-Like Receptor 1IBA 07/2017 - 01/2016
2	gnetin CIBA 01/2017 - 01/2017
2	ThrombomodulinIBA 10/2015 - 10/2015
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 02/2011 - 12/2010
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2009 - 01/2009
1	R-CHOP protocolIBA 02/2022
1	Biomarkers (Surrogate Marker)IBA 02/2022
1	VaccinesIBA 03/2021
1	fms-Like Tyrosine Kinase 3IBA 01/2020
1	gilteritinibIBA 01/2020
1	tyrosine receptor (receptor, tyrosine)IBA 01/2020
1	Phosphotransferases (Kinase)IBA 01/2020
1	ClathrinIBA 01/2020
1	Papillomavirus Vaccines (HPV Vaccines)IBA 07/2019
1	AntigensIBA 06/2019
1	IronIBA 01/2019
1	Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA 09/2018
1	fludarabineIBA 09/2018
1	SteroidsIBA 01/2018
1	DNA (Deoxyribonucleic Acid)IBA 01/2018
1	Toll-Like Receptor 2IBA 07/2017
1	Toll-Like Receptor 4IBA 07/2017
1	StilbenesIBA 01/2017
1	Chemokine ReceptorsIBA 01/2017
1	PhytochemicalsIBA 08/2016
1	Cidofovir (Vistide)FDA Link 01/2016
1	ruxolitinibIBA 11/2015
1	benphothiamine (benfotiamine)IBA 01/2015
1	Thiamine (Aneurin)FDA Link 01/2015
1	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2015
1	NucleotidesIBA 02/2013
1	Methotrexate (Mexate)FDA LinkGeneric 02/2011
1	Immunosuppressive Agents (Immunosuppressants)IBA 02/2011
1	Tacrolimus (Prograf)FDA LinkGeneric 02/2011
1	Mycophenolic Acid (Cellcept)FDA LinkGeneric 02/2011
1	Interleukin-17 (Interleukin 17)IBA 01/2011
1	InterleukinsIBA 01/2011
1	Heterogeneous-Nuclear Ribonucleoprotein KIBA 12/2010

Therapy/Procedure

11	Bone Marrow Transplantation (Transplantation, Bone Marrow) 02/2020 - 10/2009
4	Therapeutics 03/2022 - 01/2018
4	Hematopoietic Stem Cell Transplantation 10/2021 - 01/2019
2	Transplantation 01/2020 - 02/2013
1	Fecal Microbiota Transplantation 01/2022
1	Immunotherapy 01/2020
1	Blood Transfusion (Blood Transfusions) 01/2019
1	Donor Selection 01/2018
1	Chemoprevention 08/2016
1	Stem Cell Transplantation 01/2016
1	Drug Therapy (Chemotherapy) 01/2015